Werewolf Therapeutics Inc (HOWL)
2.44
-0.07
(-2.79%)
USD |
NASDAQ |
Jun 28, 16:00
2.400
-0.04
(-1.64%)
After-Hours: 20:00
Werewolf Therapeutics Total Assets (Quarterly): 177.60M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 177.60M |
| December 31, 2023 | 174.83M |
| September 30, 2023 | 176.39M |
| June 30, 2023 | 185.24M |
| March 31, 2023 | 195.07M |
| December 31, 2022 | 160.24M |
| September 30, 2022 | 172.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 175.33M |
| March 31, 2022 | 164.63M |
| December 31, 2021 | 179.25M |
| September 30, 2021 | 178.38M |
| June 30, 2021 | 190.42M |
| March 31, 2021 | 89.44M |
| December 31, 2020 | 96.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
89.44M
Minimum
Mar 2021
195.07M
Maximum
Mar 2023
165.40M
Average
175.86M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 9.902M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.01M |
| Shareholders Equity (Quarterly) | 117.59M |
| Debt to Equity Ratio | 0.3352 |
| Current Ratio | 6.707 |
| Net Debt Paydown Yield | -2.81% |